ABVC

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

ABVC Biopharma Inc

NASDAQ | ABVC

2.72

USD

$0.00

(

0.00%

)

At Close (As of Nov 19, 2025)

$64.03M

Market Cap

-

P/E Ratio

-0.25

EPS

$5.48

52 Week High

$0.40

52 Week Low

HEALTHCARE

Sector

ABVC Chart

Recent Chart
Price Action

ABVC Technicals

Tags:

ABVC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $509K
Total Revenue $510K
Cost Of Revenue $763
Costof Goods And Services Sold $763
Operating Income -$4.7M
Selling General And Administrative $5M
Research And Development $179K
Operating Expenses $5.2M
Investment Income Net -
Net Interest Income -$739K
Interest Income $87K
Interest Expense $826K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $201K
Income Before Tax -$5.4M
Income Tax Expense -$111K
Interest And Debt Expense -
Net Income From Continuing Operations -$5.3M
Comprehensive Income Net Of Tax -
Ebit -$4.5M
Ebitda -$4.3M
Net Income -$4.9M

Revenue & Profitability

Earnings Performance

ABVC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $7.5M
Total Current Assets $2.2M
Cash And Cash Equivalents At Carrying Value $864K
Cash And Short Term Investments $864K
Inventory -
Current Net Receivables $1.2M
Total Non Current Assets $5.4M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $2.3M
Short Term Investments $65K
Other Current Assets $96K
Other Non Current Assets -
Total Liabilities $6.8M
Total Current Liabilities $6.6M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt $3M
Total Non Current Liabilities $258K
Capital Lease Obligations $640K
Long Term Debt -
Current Long Term Debt $1.8M
Long Term Debt Noncurrent -
Short Long Term Debt Total $3.2M
Other Current Liabilities $3.5M
Other Non Current Liabilities $22K
Total Shareholder Equity $1.2M
Treasury Stock -
Retained Earnings -$69M
Common Stock $14K
Common Stock Shares Outstanding $12M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$1.8M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $201K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $2M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$7.3K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$5.3M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $509K
Total Revenue $510K
Cost Of Revenue $763
Costof Goods And Services Sold $763
Operating Income -$4.7M
Selling General And Administrative $5M
Research And Development $179K
Operating Expenses $5.2M
Investment Income Net -
Net Interest Income -$739K
Interest Income $87K
Interest Expense $826K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $201K
Income Before Tax -$5.4M
Income Tax Expense -$111K
Interest And Debt Expense -
Net Income From Continuing Operations -$5.3M
Comprehensive Income Net Of Tax -
Ebit -$4.5M
Ebitda -$4.3M
Net Income -$4.9M

ABVC News

ABVC Profile

ABVC Biopharma Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

ABVC Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies and medical devices that target significant unmet medical needs, primarily within the U.S. market. With a robust and diverse pipeline that encompasses both therapeutic agents and advanced drug delivery systems, ABVC is committed to improving patient outcomes across various disease indications. The company leverages cutting-edge technologies and strategic partnerships to enhance its development capabilities, positioning itself as a promising player in the biopharmaceutical sector with substantial growth potential and a commitment to impactful healthcare solutions.

LPTX
+368.57%
$2.05
AZI
+11.98%
$0.08
FRGT
+36.34%
$0.90
NVDA
+2.84%
$186.52
PLUG
-11.21%
$1.90
VHAI
+100.00%
$0.00
CHR
+20.54%
$0.05
ONDS
-4.33%
$7.50
SGBX
+78.00%
$6.07
ZYXI
+32.14%
$0.55
BURU
+3.28%
$0.21
ABEV
-2.37%
$2.47
IVP
-61.07%
$0.10
ASST
-6.25%
$1.05
NOK
-9.18%
$6.03
DNN
+2.10%
$2.43
WTO
-15.94%
$0.02
TSLA
+0.68%
$403.99
GOOGL
+3.00%
$292.81
AXDX
-61.36%
$0.03
INTC
+2.27%
$35.11
SOFI
+1.82%
$26.72
ACHR
-1.83%
$7.47
BITF
-5.45%
$2.60
PFE
-2.23%
$24.88
NUVB
+48.95%
$7.15
GRAB
-0.18%
$5.31
TLRY
-6.60%
$0.96
AMZN
+0.06%
$222.69
BYND
-2.43%
$0.97
AAL
-0.24%
$12.33
EOSE
-5.19%
$12.78
PCG
-2.66%
$15.72
AMD
-2.92%
$223.55
RIVN
-1.80%
$14.72
MARA
-6.56%
$11.10
ADAP
-15.14%
$0.05
BMNR
-9.60%
$29.18
ETHD
+11.66%
$5.84
F
-0.92%
$12.90
WBD
-2.53%
$23.09
NIO
-3.84%
$5.75
PLTR
-1.14%
$165.42
SEMR
+73.96%
$11.76
WULF
+1.91%
$12.23
GOOG
+2.81%
$292.99
EPWK
+25.36%
$1.73
IREN
-6.18%
$45.83
RGTI
-0.97%
$25.46
CIFR
+0.27%
$14.62
AAPL
+0.41%
$268.56
RMBL
+60.50%
$3.21
CAN
-6.54%
$0.96
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SNAP
-2.66%
$8.03
QBTS
+2.22%
$23.44
MU
-1.12%
$225.92
SRM
+53.27%
$10.30
BTBT
-9.24%
$2.16
T
-1.28%
$25.27
CYPH
-1.01%
$2.94
QUBT
-6.32%
$11.56
NFLX
-3.58%
$110.00
HBAN
+0.19%
$15.38
OWL
-0.86%
$13.79
KVUE
-1.04%
$16.06
ASBP
-6.14%
$0.09
STEC
+38.81%
$1.05
PLTD
+1.26%
$7.21
BBD
-1.66%
$3.54
BMNU
-18.00%
$6.92
RIG
-0.72%
$4.10
SMCI
-3.35%
$33.73
CRCL
-8.98%
$69.72
WLGS
-5.57%
$0.04
BAC
+0.73%
$52.02
MSTR
-9.81%
$186.50
MTSR
-0.35%
$70.50
RXRX
-3.12%
$4.03
APLD
+1.09%
$23.09
DVLT
-8.57%
$1.60
CLSK
-5.45%
$10.22
KZIA
+34.37%
$7.74
BTE
+1.27%
$3.18
CRWV
+0.02%
$74.92
HPE
-1.43%
$20.60
SOUN
+0.86%
$11.63
HOOD
+3.37%
$118.16
BTG
-0.50%
$3.97
PYPL
-0.74%
$60.11
CSCO
+1.31%
$78.39
META
-1.23%
$590.32
TWOH
-14.28%
$0.00
GPUS
-6.03%
$0.22
QS
-3.93%
$12.46
AFMD
-34.94%
$0.18
MSFT
-1.35%
$487.12
SMR
-1.90%
$21.13
VSA
+3.00%
$0.17
LPTX
+368.57%
$2.05
AZI
+11.98%
$0.08
FRGT
+36.34%
$0.90
NVDA
+2.84%
$186.52
PLUG
-11.21%
$1.90
VHAI
+100.00%
$0.00
CHR
+20.54%
$0.05
ONDS
-4.33%
$7.50
SGBX
+78.00%
$6.07
ZYXI
+32.14%
$0.55
BURU
+3.28%
$0.21
ABEV
-2.37%
$2.47
IVP
-61.07%
$0.10
ASST
-6.25%
$1.05
NOK
-9.18%
$6.03
DNN
+2.10%
$2.43
WTO
-15.94%
$0.02
TSLA
+0.68%
$403.99
GOOGL
+3.00%
$292.81
AXDX
-61.36%
$0.03
INTC
+2.27%
$35.11
SOFI
+1.82%
$26.72
ACHR
-1.83%
$7.47
BITF
-5.45%
$2.60
PFE
-2.23%
$24.88
NUVB
+48.95%
$7.15
GRAB
-0.18%
$5.31
TLRY
-6.60%
$0.96
AMZN
+0.06%
$222.69
BYND
-2.43%
$0.97
AAL
-0.24%
$12.33
EOSE
-5.19%
$12.78
PCG
-2.66%
$15.72
AMD
-2.92%
$223.55
RIVN
-1.80%
$14.72
MARA
-6.56%
$11.10
ADAP
-15.14%
$0.05
BMNR
-9.60%
$29.18
ETHD
+11.66%
$5.84
F
-0.92%
$12.90
WBD
-2.53%
$23.09
NIO
-3.84%
$5.75
PLTR
-1.14%
$165.42
SEMR
+73.96%
$11.76
WULF
+1.91%
$12.23
GOOG
+2.81%
$292.99
EPWK
+25.36%
$1.73
IREN
-6.18%
$45.83
RGTI
-0.97%
$25.46
CIFR
+0.27%
$14.62
AAPL
+0.41%
$268.56
RMBL
+60.50%
$3.21
CAN
-6.54%
$0.96
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SNAP
-2.66%
$8.03
QBTS
+2.22%
$23.44
MU
-1.12%
$225.92
SRM
+53.27%
$10.30
BTBT
-9.24%
$2.16
T
-1.28%
$25.27
CYPH
-1.01%
$2.94
QUBT
-6.32%
$11.56
NFLX
-3.58%
$110.00
HBAN
+0.19%
$15.38
OWL
-0.86%
$13.79
KVUE
-1.04%
$16.06
ASBP
-6.14%
$0.09
STEC
+38.81%
$1.05
PLTD
+1.26%
$7.21
BBD
-1.66%
$3.54
BMNU
-18.00%
$6.92
RIG
-0.72%
$4.10
SMCI
-3.35%
$33.73
CRCL
-8.98%
$69.72
WLGS
-5.57%
$0.04
BAC
+0.73%
$52.02
MSTR
-9.81%
$186.50
MTSR
-0.35%
$70.50
RXRX
-3.12%
$4.03
APLD
+1.09%
$23.09
DVLT
-8.57%
$1.60
CLSK
-5.45%
$10.22
KZIA
+34.37%
$7.74
BTE
+1.27%
$3.18
CRWV
+0.02%
$74.92
HPE
-1.43%
$20.60
SOUN
+0.86%
$11.63
HOOD
+3.37%
$118.16
BTG
-0.50%
$3.97
PYPL
-0.74%
$60.11
CSCO
+1.31%
$78.39
META
-1.23%
$590.32
TWOH
-14.28%
$0.00
GPUS
-6.03%
$0.22
QS
-3.93%
$12.46
AFMD
-34.94%
$0.18
MSFT
-1.35%
$487.12
SMR
-1.90%
$21.13
VSA
+3.00%
$0.17
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.